qy101
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2022 (NCT05429177)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06170840 | Phase 2 | May 17, 2023 | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. |
| NCT05429177 | Phase 1 | Jun 30, 2022 | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd., Zhejiang University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | For profit | 2 | 2 | 2 | 2022 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1